Chen Ying, Zhang Xin-Jiang, Zhao Yu-Liang, Zhang Yan-Hong, Wang Song-Mei, Hao Zhi-Yong, Zhang Zhi-Yong, Ma Jing-Chen, Fang Yun, Wang Xuan-Yi
Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, People's Republic of China.
Zhengding County Center for Disease Control and Prevention, Zhengding 050800, People's Republic of China.
Vaccine. 2014 Oct 29;32(47):6227-32. doi: 10.1016/j.vaccine.2014.09.022. Epub 2014 Sep 22.
To study the epidemiological patterns of hepatitis A, and immunity of entire population in Shijiazhuang prefecture, Hebei province, a former hyper-endemic area in north China.
Cross-sectional, seroprevalence surveys with two-stage cluster sampling were conducted among population older than 2-year between 1992 and 2011. During the 2011 serological survey, blood samples from infants <18 months without hepatitis A immunization history were also collected to determine maternal anti-HAV antibody. Serum samples were tested for anti-HAV antibody by domestic reagent or Abbott reagent. Viral hepatitis incidence rates and gross domestic product data were derived from local governmental statistics.
Concomitant with the reduction of reported hepatitis A cases between 1992 and 1996 was a significant decline of HAV infections. The average prevalence decreased from 93.6% to 41.9%, and the average age at new infection was postponed from infancy to adolescence. This was attributed to improved socio-economic conditions. With intensive vaccination, a return of new seroconversion rate and seroprevalence was observed. A well fitted exponential regression equation (R(2)=0.96, p<0.0001) modeled that the maternal antibody would wane to <20 mIU/mL at 13 months.
Benefiting from the booming economy, rapid improvement in sanitation, safe water supply, and implementation of hepatitis A vaccines, the epidemiological pattern of hepatitis A moved from high to intermediate endemicity in Shijiazhuang. Policy makers should be aware of the waning of immunity in entire population, and adapt immunization strategy timely, to ensure a lifelong protection against hepatitis A virus.
研究河北省石家庄市(中国北方一个既往甲型肝炎高度流行地区)甲型肝炎的流行病学模式及全人群的免疫情况。
1992年至2011年期间,采用两阶段整群抽样的横断面血清学现况调查方法,对2岁以上人群进行调查。在2011年血清学调查期间,还收集了18个月以下无甲型肝炎免疫史婴儿的血样,以检测母体抗甲型肝炎病毒(HAV)抗体。血清样本采用国产试剂或雅培试剂检测抗HAV抗体。病毒性肝炎发病率和国内生产总值数据来自当地政府统计资料。
1992年至1996年期间,随着报告的甲型肝炎病例数减少,HAV感染也显著下降。平均患病率从93.6%降至41.9%,新感染的平均年龄从婴儿期推迟到青春期。这归因于社会经济条件的改善。随着强化疫苗接种,观察到新的血清转化率和血清阳性率有所回升。一个拟合良好的指数回归方程(R² = 0.96,p < 0.0001)模拟显示,母体抗体在13个月时将降至<20 mIU/mL。
得益于经济蓬勃发展、卫生条件迅速改善、安全供水以及甲型肝炎疫苗的实施,石家庄市甲型肝炎的流行病学模式已从高度流行转变为中度流行。政策制定者应意识到全人群免疫力的下降,并及时调整免疫策略,以确保对甲型肝炎病毒的终身保护。